Cargando…

Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation

Malaria caused by Plasmodium falciparum causes numerous cases of morbidity with about 400,000 deaths yearly owing, mainly, to inflammation leading to cerebral malaria (CM). CM conventionally is treated by repetitive administration of anti-plasmodial drugs and supportive non-specific drugs, for about...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golenser, Jacob, Salaymeh, Nadeen, Higazi, Abd Alroof, Alyan, Mohammed, Daif, Mahran, Dzikowski, Ron, Domb, Abraham J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303303/ https://www.ncbi.nlm.nih.gov/pubmed/32595499 http://dx.doi.org/10.3389/fphar.2020.00846

Ejemplares similares

Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy
por: Zech, Johanna, et al.
Publicado: (2020)

Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency
por: Zech, Johanna, et al.
Publicado: (2021)

Controlled release of artemisone for the treatment of experimental cerebral malaria
por: Golenser, Jacob, et al.
Publicado: (2017)

Elimination of Schistosoma mansoni in infected mice by slow release of artemisone
por: Gold, Daniel, et al.
Publicado: (2017)

Artemisone effective against murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010)

Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria
por: Zech, Johanna, et al.
Publicado: (2021)

Bier and Pastis, a pixel readout prototype chip for LHC
por: Berg, C, et al.
Publicado: (2000)

Synthesis and biological evaluation of novel artemisone–piperazine–tetronamide hybrids
por: Wei, Meng-Xue, et al.
Publicado: (2021)

Cisplatin Tumor Biodistribution and Efficacy after Intratumoral Injection of a Biodegradable Extended Release Implant
por: Shikanov, Ariella, et al.
Publicado: (2011)

The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment
por: Pauls, Mathilde M.H., et al.
Publicado: (2022)

Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial
por: Pauls, Mathilde MH, et al.
Publicado: (2023)

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
por: Wong, Ho Ning, et al.
Publicado: (2020)

Association between tissue human neutrophil peptide 1–3 levels and cardiovascular phenotype: a prospective, longitudinal cohort study
por: Abu Fanne, Rami, et al.
Publicado: (2022)

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue
por: Ng, Jerome P. L., et al.
Publicado: (2022)

Emerging biology of noncoding RNAs in malaria parasites
por: Simantov, Karina, et al.
Publicado: (2022)

Screening for an ivermectin slow-release formulation suitable for malaria vector control
por: Chaccour, Carlos, et al.
Publicado: (2015)

Mutually Exclusive Expression of Virulence Genes by Malaria Parasites Is Regulated Independently of Antigen Production
por: Dzikowski, Ron, et al.
Publicado: (2006)

The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside
por: Gibhard, Liezl, et al.
Publicado: (2021)

Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial
por: Pauls, Mathilde M. H., et al.
Publicado: (2017)

Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects
por: Baldassari, Sara, et al.
Publicado: (2018)

Use of Peptide Nucleic Acids to Manipulate Gene Expression in the Malaria Parasite Plasmodium falciparum
por: Kolevzon, Netanel, et al.
Publicado: (2014)

An SR protein is essential for activating DNA repair in malaria parasites
por: Goyal, Manish, et al.
Publicado: (2021)

Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation
por: Müller, Joachim, et al.
Publicado: (2022)

PAin SoluTions In the Emergency Setting (PASTIES)—patient controlled analgesia versus routine care in emergency department patients with pain from traumatic injuries: randomised trial
por: Smith, Jason E, et al.
Publicado: (2015)

PAin SoluTions In the Emergency Setting (PASTIES)—patient controlled analgesia versus routine care in emergency department patients with non-traumatic abdominal pain: randomised trial
por: Smith, Jason E, et al.
Publicado: (2015)

PAin SoluTions In the Emergency Setting (PASTIES); a protocol for two open-label randomised trials of patient-controlled analgesia (PCA) versus routine care in the emergency department
por: Smith, Jason E, et al.
Publicado: (2013)

Phosphorylation of the Canonical Histone H2A Marks Foci of Damaged DNA in Malaria Parasites
por: Goyal, Manish, et al.
Publicado: (2021)

Effects of a Pasty Bone Cement Containing Brain-Derived Neurotrophic Factor-Functionalized Mesoporous Bioactive Glass Particles on Metaphyseal Healing in a New Murine Osteoporotic Fracture Model
por: Kauschke, Vivien, et al.
Publicado: (2018)

Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria
por: Portnoy, Emma, et al.
Publicado: (2016)

Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria
por: Zelter, Tamir, et al.
Publicado: (2022)

Formulation of a Hybrid Nanofertilizer for Slow and Sustainable Release of Micronutrients
por: Tarafder, Chaitaly, et al.
Publicado: (2020)

Reduction of Experimental Cerebral Malaria and Its Related Proinflammatory Responses by the Novel Liposome-Based β-Methasone Nanodrug
por: Guo, Jintao, et al.
Publicado: (2014)

The use of slow-cycling synchrotrons in injection systems
Publicado: (1966)

Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study
por: Abd Elraouf, Israa Gomaa, et al.
Publicado: (2023)

Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation
por: Serna, Naroa, et al.
Publicado: (2023)

An upstream open reading frame (uORF) signals for cellular localization of the virulence factor implicated in pregnancy associated malaria
por: Fastman, Yair, et al.
Publicado: (2018)

Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation
por: Chaccour, Carlos J., et al.
Publicado: (2018)

Schistosoma mansoni infection reduces the incidence of murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010)

Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control
por: Jiang, Bin, et al.
Publicado: (2017)

Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin
por: Omer, Ahmed M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jmjfu6ild9tg8ot4m02eme98fb